Top 100 Contractors in PSC 65: Medical/Dental/Veterinary Equipment/Supplies, FY2022

Parent companies by net contract obligations Oct 1, 2021 – Sep 30, 2022 Code page on GovTribe

The top 10 won 76% of FY2022 PSC 65 contract dollars

Ranking facts

Contract obligations
$51,220,344,829 Net of deobligations, by contracts coded PSC 65 or a code under it
Contractors
3,810 Parent companies with an obligation
Largest contractor
Pfizer Inc. $18 billion, 32.2% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $18,008,355,256
Rank history: #1 in FY2021, #4 in FY2023 and not on the FY2024–FY2025 lists; unchanged since FY2021.
2 $11,740,061,443
Rank history: #2 in FY2021, #1 in FY2023, #1 in FY2024 and #1 in FY2025; unchanged since FY2021.
3 $2,752,650,080
Rank history: #6 in FY2021 and not on the FY2023–FY2025 lists; up 3 since FY2021.
4
Modernatx Inc. 2 awardees, including Moderna US, Inc.
$1,847,427,026
Rank history: #3 in FY2021 and not on the FY2023–FY2025 lists; down 1 since FY2021.
5
Ihealth Labs Inc.
$1,775,000,059
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
6 $1,629,156,450
Rank history: #10 in FY2021, not on the FY2023 list, #35 in FY2024 and #57 in FY2025; up 4 since FY2021.
7 $1,542,551,821
Rank history: #5 in FY2021, #3 in FY2023, #2 in FY2024 and #2 in FY2025; down 2 since FY2021.
8 $1,454,084,289
Rank history: #16 in FY2021, #7 in FY2023 and not on the FY2024–FY2025 lists; up 8 since FY2021.
9 $997,227,362
Rank history: #7 in FY2021, #53 in FY2023 and not on the FY2024–FY2025 lists; down 2 since FY2021.
10 $800,421,758
Rank history: #19 in FY2021, #15 in FY2023, #68 in FY2024 and not on the FY2025 list; up 9 since FY2021.
11 $620,685,727
Rank history: #8 in FY2021, #5 in FY2023, #11 in FY2024 and not on the FY2025 list; down 3 since FY2021.
12 $610,066,309
Rank history: #61 in FY2021, #23 in FY2023, #79 in FY2024 and not on the FY2025 list; up 49 since FY2021.
13 $576,004,991
Rank history: #9 in FY2021 and not on the FY2023–FY2025 lists; down 4 since FY2021.
14
Amerisourcebergen Corporation Through Amerisourcebergen Drug Corp
$330,374,810
Rank history: not on the FY2021 list, #2 in FY2023, #3 in FY2024 and not on the FY2025 list; new.
15 $293,125,000
Rank history: #28 in FY2021, #24 in FY2023, #10 in FY2024 and #14 in FY2025; up 13 since FY2021.
16 $280,419,862
Rank history: #11 in FY2021, #6 in FY2023, #6 in FY2024 and #3 in FY2025; down 5 since FY2021.
17 $261,524,616
Rank history: #13 in FY2021, #9 in FY2023, #9 in FY2024 and #5 in FY2025; down 4 since FY2021.
18 $208,451,516
Rank history: #14 in FY2021, #14 in FY2023, #12 in FY2024 and #8 in FY2025; down 4 since FY2021.
19 $190,221,064
Rank history: #18 in FY2021, not on the FY2023 list, #8 in FY2024 and #10 in FY2025; down 1 since FY2021.
20 $187,881,150
Rank history: #17 in FY2021, #11 in FY2023, #7 in FY2024 and not on the FY2025 list; down 3 since FY2021.
21 $161,219,888
Rank history: #23 in FY2021, #21 in FY2023, #16 in FY2024 and #16 in FY2025; up 2 since FY2021.
22 $139,921,289
Rank history: not on the FY2021 list, not on the FY2023–FY2024 lists and #18 in FY2025; new.
23 $138,981,450
Rank history: #45 in FY2021, #16 in FY2023, #13 in FY2024 and #13 in FY2025; up 22 since FY2021.
24 $137,523,972
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 211 since FY2021.
25 $126,904,912
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
26 $118,928,428
Rank history: not on the FY2021 list, #62 in FY2023, not on the FY2024 list and #34 in FY2025; new.
27 $117,208,312
Rank history: #39 in FY2021, #54 in FY2023, #93 in FY2024 and #27 in FY2025; up 12 since FY2021.
28 $115,401,814
Rank history: #75 in FY2021, #20 in FY2023, #15 in FY2024 and #12 in FY2025; up 47 since FY2021.
29 $112,074,407
Rank history: #31 in FY2021 and not on the FY2023–FY2025 lists; up 2 since FY2021.
30 $103,228,601
Rank history: #36 in FY2021, #26 in FY2023, #22 in FY2024 and #20 in FY2025; up 6 since FY2021.
31 $101,549,934
Rank history: #12 in FY2021, #10 in FY2023 and not on the FY2024–FY2025 lists; down 19 since FY2021.
32 $92,861,984
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
33 $89,737,209
Rank history: #43 in FY2021, #27 in FY2023, #24 in FY2024 and #19 in FY2025; up 10 since FY2021.
34 $88,759,722
Rank history: #47 in FY2021, #28 in FY2023 and not on the FY2024–FY2025 lists; up 13 since FY2021.
35 $81,148,543
Rank history: #72 in FY2021 and not on the FY2023–FY2025 lists; up 37 since FY2021.
36 $79,869,432
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
37 $76,478,401
Rank history: #80 in FY2021, #89 in FY2023, #29 in FY2024 and #50 in FY2025; up 43 since FY2021.
38 $72,141,704
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
39 $70,435,382
Rank history: #49 in FY2021, #40 in FY2023, #25 in FY2024 and #67 in FY2025; up 10 since FY2021.
40 $69,022,027
Rank history: #40 in FY2021, #39 in FY2023, #34 in FY2024 and #31 in FY2025; unchanged since FY2021.
41 $64,543,688
Rank history: #29 in FY2021, #34 in FY2023, #44 in FY2024 and #44 in FY2025; down 12 since FY2021.
42 $62,406,604
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
43 $59,373,438
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
44 $59,026,988
Rank history: not on the FY2021 list, #74 in FY2023, #71 in FY2024 and #41 in FY2025; new.
45 $55,943,980
Rank history: #38 in FY2021, #47 in FY2023, #49 in FY2024 and #29 in FY2025; down 7 since FY2021.
46 $54,867,520
Rank history: #41 in FY2021, #31 in FY2023, #31 in FY2024 and #25 in FY2025; down 5 since FY2021.
47
William Demants OG Hustru IDA Emilies (MILLAS) Fond - Kaldet 13 awardees, including Oticon, Inc., E3 Diagnostics, Inc. and Diagnostic Group LLC
$54,808,098
Rank history: #71 in FY2021, #29 in FY2023, #72 in FY2024 and not on the FY2025 list; up 24 since FY2021.
48 $54,640,000
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
49 $53,760,695
Rank history: #42 in FY2021, #35 in FY2023, #48 in FY2024 and #48 in FY2025; down 7 since FY2021.
50 $52,670,280
Rank history: #53 in FY2021 and not on the FY2023–FY2025 lists; up 3 since FY2021.
51 $52,005,388
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
52 $51,599,939
Rank history: #46 in FY2021 and not on the FY2023–FY2025 lists; down 6 since FY2021.
53 $49,219,292
Rank history: #51 in FY2021, #36 in FY2023, #38 in FY2024 and #23 in FY2025; down 2 since FY2021.
54 $48,332,504
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
55 $47,907,072
Rank history: not on the FY2021 list, #49 in FY2023, #18 in FY2024 and #26 in FY2025; new.
56 $46,593,667
Rank history: #55 in FY2021, #42 in FY2023, #47 in FY2024 and #49 in FY2025; down 1 since FY2021.
57 $39,507,834
Rank history: #81 in FY2021, #69 in FY2023 and not on the FY2024–FY2025 lists; up 24 since FY2021.
58 $38,985,952
Rank history: #78 in FY2021, #19 in FY2023, #42 in FY2024 and not on the FY2025 list; up 20 since FY2021.
59 $38,198,599
Rank history: #58 in FY2021, #43 in FY2023 and not on the FY2024–FY2025 lists; down 1 since FY2021.
60
Teva Pharmaceutical Industries Ltd. Through Teva Pharmaceuticals Usa, Inc.
$35,215,784
Rank history: #63 in FY2021, #50 in FY2023 and not on the FY2024–FY2025 lists; up 3 since FY2021.
61 $34,184,983
Rank history: #74 in FY2021, #65 in FY2023, #80 in FY2024 and not on the FY2025 list; up 13 since FY2021.
62 $33,347,313
Rank history: #85 in FY2021, #55 in FY2023 and not on the FY2024–FY2025 lists; up 23 since FY2021.
63 $32,831,953
Rank history: #90 in FY2021, #67 in FY2023 and not on the FY2024–FY2025 lists; up 27 since FY2021.
64 $32,155,142
Rank history: #60 in FY2021, #61 in FY2023 and not on the FY2024–FY2025 lists; down 4 since FY2021.
65 $31,291,020
Rank history: not on the FY2021 list, not on the FY2023 list, #54 in FY2024 and not on the FY2025 list; new.
66 $30,867,660
Rank history: #54 in FY2021 and not on the FY2023–FY2025 lists; down 12 since FY2021.
67 $30,777,661
Rank history: #65 in FY2021, #45 in FY2023, #70 in FY2024 and not on the FY2025 list; down 2 since FY2021.
68 $30,184,749
Rank history: #67 in FY2021, #44 in FY2023, #40 in FY2024 and #33 in FY2025; down 1 since FY2021.
69 $29,712,992
Rank history: #20 in FY2021, #37 in FY2023, #61 in FY2024 and #40 in FY2025; down 49 since FY2021.
70 $29,366,566
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
71 $26,378,825
Rank history: not on the FY2021 list, #60 in FY2023 and not on the FY2024–FY2025 lists; up 37 since FY2021.
72 $25,744,118
Rank history: not on the FY2021 list, #79 in FY2023, #62 in FY2024 and #73 in FY2025; up 281 since FY2021.
73 $25,521,675
Rank history: #89 in FY2021, #91 in FY2023, #94 in FY2024 and not on the FY2025 list; up 16 since FY2021.
74 $25,497,810
Rank history: #94 in FY2021, #56 in FY2023 and not on the FY2024–FY2025 lists; up 20 since FY2021.
75 $24,221,430
Rank history: #73 in FY2021, #46 in FY2023, #57 in FY2024 and #38 in FY2025; down 2 since FY2021.
76 $23,690,122
Rank history: #84 in FY2021, #30 in FY2023, #90 in FY2024 and not on the FY2025 list; up 8 since FY2021.
77 $22,898,798
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
78 $22,804,570
Rank history: #30 in FY2021 and not on the FY2023–FY2025 lists; down 48 since FY2021.
79 $22,671,660
Rank history: #57 in FY2021, #41 in FY2023, not on the FY2024 list and #76 in FY2025; down 22 since FY2021.
80 $22,179,577
Rank history: not on the FY2021 list, not on the FY2023 list, #28 in FY2024 and not on the FY2025 list; up 35 since FY2021.
81 $21,147,403
Rank history: #88 in FY2021, #83 in FY2023 and not on the FY2024–FY2025 lists; up 7 since FY2021.
82 $20,982,192
Rank history: #82 in FY2021, #63 in FY2023 and not on the FY2024–FY2025 lists; unchanged since FY2021.
83 $20,920,993
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 26 since FY2021.
84 $20,551,559
Rank history: #98 in FY2021, #97 in FY2023 and not on the FY2024–FY2025 lists; up 14 since FY2021.
85 $20,451,539
Rank history: #15 in FY2021, #81 in FY2023 and not on the FY2024–FY2025 lists; down 70 since FY2021.
86 $20,301,930
Rank history: not on the FY2021 list, #86 in FY2023 and not on the FY2024–FY2025 lists; up 44 since FY2021.
87 $20,120,301
Rank history: not on the FY2021 list, #72 in FY2023, #73 in FY2024 and #69 in FY2025; up 24 since FY2021.
88 $19,761,362
Rank history: not on the FY2021 list, #73 in FY2023 and not on the FY2024–FY2025 lists; up 18 since FY2021.
89 $19,087,215
Rank history: #87 in FY2021, #82 in FY2023, not on the FY2024 list and #79 in FY2025; down 2 since FY2021.
90 $18,436,332
Rank history: not on the FY2021 list, #94 in FY2023 and not on the FY2024–FY2025 lists; new.
91 $18,221,859
Rank history: not on the FY2021 list, not on the FY2023–FY2024 lists and #59 in FY2025; up 44 since FY2021.
92 $18,217,867
Rank history: not on the FY2021 list, #85 in FY2023 and not on the FY2024–FY2025 lists; up 11 since FY2021.
93 $18,185,302
Rank history: #70 in FY2021, #57 in FY2023 and not on the FY2024–FY2025 lists; down 23 since FY2021.
94 $17,902,059
Rank history: #97 in FY2021, #84 in FY2023 and not on the FY2024–FY2025 lists; up 3 since FY2021.
95 $17,678,367
Rank history: #93 in FY2021, #75 in FY2023 and not on the FY2024–FY2025 lists; down 2 since FY2021.
96 $17,272,534
Rank history: not on the FY2021 list, #90 in FY2023, #100 in FY2024 and #80 in FY2025; up 14 since FY2021.
97 $15,905,682
Rank history: #86 in FY2021 and not on the FY2023–FY2025 lists; down 11 since FY2021.
98 $15,899,969
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 27 since FY2021.
99 $15,682,260
Rank history: #62 in FY2021, #52 in FY2023, #75 in FY2024 and #99 in FY2025; down 37 since FY2021.
100 $15,556,051
Rank history: not on the FY2021 list, #96 in FY2023 and not on the FY2024–FY2025 lists; up 7 since FY2021.
Show 75 more

100 of 3,810 contractors listed here. See the rest on GovTribe.

Rankings for the codes under PSC 65

Code Net obligations Largest contractor
6505 Drugs and Biologicals $40,718,726,583 Pfizer Inc.
6515 Medical and Surgical Instruments, Equipment, and Supplies $7,803,487,170 Ihealth Labs Inc.
6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets $1,223,507,144 Astrazeneca PLC
6525 X-Ray Equipment and Supplies: Medical, Dental, Veterinary $936,775,735 Siemens Aktiengesellschaft
6530 Hospital Furniture, Equipment, Utensils, and Supplies $386,285,751 Arthrex Inc.
6540 Ophthalmic Instruments, Equipment, and Supplies $47,999,386 PDS Consultants, Inc.
6520 Dental Instruments, Equipment, and Supplies $38,526,025 Katmai Health Services LLC
6545 Replenishable Field Medical Sets, Kits, and Outfits $31,822,268 Southeastern Kentucky Rehabilitation Industries, Inc.
6509 Drugs and Biologicals, Veterinary Use $12,080,588 Patterson Companies, Inc.
6532 Hospital and Surgical Clothing and Related Special Purpose Items $10,908,772 Arbill Industries Inc.
6510 Surgical Dressing Materials $9,112,993 Stratatech Corporation

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $55.9 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2022 ran Oct 1, 2021 – Sep 30, 2022. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2021. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2021 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC 65 contractors in FY2022?

1. Pfizer Inc. ($18B), 2. Mckesson Corporation ($11.7B), 3. ELI Lilly and Company ($2.75B), 4. Modernatx Inc. ($1.85B), 5. Ihealth Labs Inc. ($1.78B), 6. Glaxosmithkline LLC ($1.63B), 7. Cencora, Inc. ($1.54B), 8. Abbott Laboratories ($1.45B), 9. Merck & Co. Inc. ($997M), 10. Siemens Aktiengesellschaft ($800M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work